These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26156679)

  • 1. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
    Atay D; Erbey F; Akcay A; Ozturk G
    Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation.
    Grube M; Wolff D; Ahrens N; Herzberg PY; Herr W; Holler E
    Clin Transplant; 2016 Nov; 30(11):1457-1465. PubMed ID: 27618621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.
    Damodar S; Shanley R; MacMillan M; Ustun C; Weisdorf D
    Biol Blood Marrow Transplant; 2017 May; 23(5):795-804. PubMed ID: 28232088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?
    Gutiérrez-Aguirre CH; Gómez-De-León A; Alatorre-Ricardo J; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; Mancías-Guerra C; Flores-Jiménez JA; Gómez-Almaguer D
    Transfusion; 2014 May; 54(5):1269-77. PubMed ID: 24898453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO incompatible stem cell transplantation in children does not influence outcome.
    Helming AM; Brand A; Wolterbeek R; van Tol MJ; Egeler RM; Ball LM
    Pediatr Blood Cancer; 2007 Sep; 49(3):313-7. PubMed ID: 16960869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Ataca Atilla P; Akkus E; Atilla E; Gokmen N; Civriz Bozdag S; Kocak Toprak S; Kurt Yuksel M; Ozcan M; Demirer T; Ilhan O; Beksac M; Akan H; Arslan O; Topcuoglu P; Gurman G
    Transfus Clin Biol; 2020 Aug; 27(3):115-121. PubMed ID: 32659269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
    Maciej Zaucha J; Mielcarek M; Takatu A; Little MT; Gooley T; Baker J; Maloney DG; Sandmaier BM; Maris M; Chauncey T; Storb R; Torok-Storb B
    Br J Haematol; 2002 Dec; 119(3):740-50. PubMed ID: 12437653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of ABO-incompatibility on allogeneic hematopoietic stem cell transplantation].
    Bao L; Huang XJ; Liu KY; Xu LP; Chen H; Zhang YC; Chen YH; Han W; Lu DP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):126-9. PubMed ID: 15841137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ABO-Incompatibility on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation].
    Yang BB; Gan YF; Chen P; Chen Y; Yu K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):535-540. PubMed ID: 28446307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ABO-incompatible allogeneic stem cell transplantation on erythroid lineage hematopoiesis].
    Cai XJ; Hong JY; Chen Y; Yu K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):801-4. PubMed ID: 21729575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.
    Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Min WS; Kim CC; Lee MH; Lee JJ; Chung IJ; Kim HJ; Lee JW
    Bone Marrow Transplant; 2005 Mar; 35(5):489-95. PubMed ID: 15654350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
    Schetelig J; Breitschaft A; Kröger N; Zabelina T; Ebell W; Bornhäuser M; Haack A; Ehninger G; Salama A; Siegert W;
    Transfusion; 2005 May; 45(5):779-87. PubMed ID: 15847669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.